Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron

Zhen Cui(Chinese Academy of Sciences), Pan Liu(Chinese Academy of Sciences), Nan Wang(Chinese Academy of Sciences), Lei Wang(Chinese Academy of Sciences), Kaiyue Fan(Chinese Academy of Sciences), Qianhui Zhu(Chinese Academy of Sciences), Kang Wang(Chinese Academy of Sciences), Ruihong Chen(Guangzhou Medical University), Rui Feng(Chinese Academy of Sciences), Zijing Jia(Chinese Academy of Sciences), Minnan Yang(Chinese Academy of Sciences), Ge Xu(Chinese Academy of Sciences), Boling Zhu(Chinese Academy of Sciences), Wangjun Fu(Chinese Academy of Sciences), Tianming Chu(Chinese Academy of Sciences), Leilei Feng(Chinese Academy of Sciences), Yide Wang(Chinese Academy of Sciences), Xinran Pei(Chinese Academy of Sciences), Peng Yang(Chinese Academy of Sciences), Xiaoliang Sunney Xie(Peking University), Lei Cao(Chinese Academy of Sciences), Yunlong Cao(Peking University), Xiangxi Wang(Chinese Academy of Sciences)
Cell
January 25, 2022
Cited by 470Open Access
Full Text

Abstract

The SARS-CoV-2 Omicron variant with increased fitness is spreading rapidly worldwide. Analysis of cryo-EM structures of the spike (S) from Omicron reveals amino acid substitutions forging interactions that stably maintain an active conformation for receptor recognition. The relatively more compact domain organization confers improved stability and enhances attachment but compromises the efficiency of the viral fusion step. Alterations in local conformation, charge, and hydrophobic microenvironments underpin the modulation of the epitopes such that they are not recognized by most NTD- and RBD-antibodies, facilitating viral immune escape. Structure of the Omicron S bound with human ACE2, together with the analysis of sequence conservation in ACE2 binding region of 25 sarbecovirus members, as well as heatmaps of the immunogenic sites and their corresponding mutational frequencies, sheds light on conserved and structurally restrained regions that can be used for the development of broad-spectrum vaccines and therapeutics.


Related Papers

No related papers found

Powered by citation graph analysis